The diagnosis of HCC is increasingly made with the use of noninvasive imaging tests such as ultrasonography, computed tomography (CT) and magnetic resonance tomography (MRI), along with use of an alpha-fetoprotein (AFP) level, a predictive biomarker for HCC. Here, AFP is linked to hepatocellular carcinoma.